Insmed (INSM)

INSM trades at $157.16, 12.3% above the near-term max pain of $140 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($70-$140), reflecting growing call interest at higher strikes. Key magnetic zone at 140 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for INSM shows an upward trend from 70 to 140, suggesting bullish positioning in longer-dated options. The 62% spread signals divergent expectations across timeframes. Most levels below 157.16 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.